Category: Latest News
-
Costco Beats Forecasts as Comparable Sales Rise 6.4%
Costco Wholesale Corp (NASDAQ:COST) reported stronger-than-expected earnings and revenue for its fiscal first quarter of 2026, although its shares edged 0.6% lower in U.S. premarket trading on Friday. Net income for the period climbed to $2.0 billion, equivalent to $4.50 per diluted share, surpassing analysts’ expectations of $4.28 per share. Revenue increased 8.3% year-on-year to…
-
Lululemon Shares Surge After CEO Exit Announcement and Upgraded Outlook
Shares of Lululemon athletica (NASDAQ:LULU) climbed about 9% in U.S. premarket trading on Friday after the company announced that chief executive Calvin McDonald will step down, alongside an improvement to its full-year profit guidance. McDonald is expected to depart in January, bringing to an end his seven-year tenure leading the premium athleisure brand. No immediate…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures, Broadcom, Costco Earnings and Lululemon CEO Exit Shape Market Moves
U.S. equity futures pointed to a mixed start on Friday, the final session of the trading week. Broadcom (NASDAQ:AVGO) shares slipped in after-hours trading after the chipmaker’s update reignited concerns about the rising cost of artificial intelligence investments. Costco (NASDAQ:COST) delivered quarterly results that exceeded expectations, highlighting resilient demand for value-priced goods as consumers remain…
-
Dow Jumps To New Record Closing High But Nasdaq Closes Modestly Lower
The major U.S. stock indexes moved in starkly opposite directions in early trading on Thursday, with the Dow moving sharply higher and the Nasdaq showing a significant pullback. While the Nasdaq climbed well off its worst levels of the day, the tech-heavy index still closed down 60 points or 0.3 percent at 23,594. Meanwhile, the…
-
U.S. Jobless Claims Jump More Than Expected as Filings Rebound
New data from the Labor Department showed a sharper-than-anticipated rise in first-time unemployment claims for the week ending December 6th, signaling a notable uptick in layoffs. Initial jobless claims climbed to 236,000, up 44,000 from the prior week’s revised figure of 192,000. Economists had been looking for a much smaller increase, forecasting claims at 220,000…
-
U.S. Trade Gap Narrows Unexpectedly as Exports Surge in September
The U.S. trade deficit contracted far more than anticipated in September, driven by a robust rebound in exports, according to government data released Thursday. New figures from the Commerce Department show the trade gap narrowed to $52.8 billion, down from a revised $59.3 billion in August. Economists had been bracing for the deficit to widen…
-
Dow Jones, S&P, Nasdaq, Futures, Oracle Selloff Poised to Pressure Wall Street at the Open
U.S. equity futures signaled a weaker start on Thursday, suggesting the market may surrender some of the gains logged in the previous session. A sharp premarket decline in Oracle (NYSE:ORCL) is set to drag on sentiment, with the tech firm tumbling 13.1% before the bell. The slide follows the company’s fiscal second-quarter update, which delivered…
-
Oil Prices Edge Lower as Markets Weigh U.S. Tanker Seizure and Fresh IEA Outlook
Crude prices slipped on Thursday, giving back part of Wednesday’s rally as traders assessed the implications of a U.S. seizure of a sanctioned Venezuelan tanker and evaluated the latest projections from the International Energy Agency. By 08:00 ET (13:00 GMT), February Brent futures were down 1.1% at $61.53 a barrel, while West Texas Intermediate crude…
-
Manchester United Shares Drop as Q1 Results Fall Short of Analyst Expectations
Manchester United plc (NYSE:MANU) slipped 4.16% in premarket trading on Thursday after the club posted fiscal first-quarter 2026 revenue of £140.3 million — just under the £141.05 million analysts had forecast and down 2% from £143.1 million a year earlier. The Premier League club reported an adjusted loss per share of £1.48, sharply below expectations…
-
Eli Lilly Shares Rise After Retatrutide Delivers Striking Weight-Loss and Pain-Relief Results in Phase 3 Study
Eli Lilly (NYSE:LLY) climbed 3% in premarket trading Thursday after unveiling landmark Phase 3 data for its experimental triple-agonist therapy, retatrutide, showing extraordinary levels of weight reduction alongside major improvements in osteoarthritis symptoms. In the TRIUMPH-4 study, individuals with obesity and knee osteoarthritis who received the highest 12 mg dose lost an average of 28.7%…